Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Immunomodulation induced by NBI-6024 in type 1 diabetic patients

June 10, 2005

New treatments for diabetes reported in recent patent literature

June 8, 2005

Ligand earns new milestone from GSK collaboration

June 8, 2005

Update on preclinical pharmacological profile of tanaproget

June 8, 2005

DiaKine acquires IND application for lisofylline

June 7, 2005

New phase IIb dose-finding study for obesity drug AOD-9604

June 7, 2005

U.S. approval for Glumetza

June 7, 2005

TH-9507 reported to improve serum lipid parameters

June 7, 2005

Herstatin: a new endogenous insulin sensitizer

June 7, 2005

CTCE-0214 induces stem cell mobilization in a phase I study

June 6, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...